VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $834,210 | +2670.5% | 31,000 | +3000.0% | 0.00% | – |
| Q2 2023 | $30,110 | -6.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $32,350 | -91.3% | 1,000 | -92.3% | 0.00% | -100.0% |
| Q4 2022 | $372,580 | +19.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $313,000 | -11.8% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $355,000 | -32.3% | 13,000 | -4.9% | 0.00% | -50.0% |
| Q1 2022 | $524,000 | +19.9% | 13,667 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $437,000 | +3.6% | 13,667 | -4.7% | 0.00% | -50.0% |
| Q3 2021 | $422,000 | -13.3% | 14,334 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $487,000 | +9.7% | 14,334 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $444,000 | -30.4% | 13,666 | -22.9% | 0.00% | -33.3% |
| Q4 2020 | $638,000 | -13.0% | 17,727 | -5.3% | 0.00% | -25.0% |
| Q3 2020 | $733,000 | +33.3% | 18,727 | +24.8% | 0.00% | +33.3% |
| Q2 2020 | $550,000 | +59.4% | 15,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $345,000 | -22.1% | 15,000 | -1.0% | 0.00% | 0.0% |
| Q4 2019 | $443,000 | +9.7% | 15,145 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $404,000 | +5.5% | 15,145 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $383,000 | +14.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $336,000 | +6.3% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $316,000 | +14.1% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $277,000 | -17.1% | 15,000 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $334,000 | +1.5% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $329,000 | -6.0% | 15,000 | -0.4% | 0.00% | 0.0% |
| Q4 2017 | $350,000 | +1.4% | 15,066 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $345,000 | -5.5% | 15,066 | -9.1% | 0.00% | 0.0% |
| Q2 2017 | $365,000 | -24.0% | 16,566 | -21.4% | 0.00% | -33.3% |
| Q1 2017 | $480,000 | +9.1% | 21,066 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $440,000 | -20.9% | 21,066 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $556,000 | -2.3% | 21,066 | +2.4% | 0.00% | 0.0% |
| Q2 2016 | $569,000 | – | 20,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |